Johannes Brägelmann (J Brägelmann)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 15

Top Venues

Cell death & disease

Cancers

Cancer research

Hepatology (Baltimore, Md.)

This page only lists publications with an associated author ORCID identifier.

Publications

L Valdez Capuccino, T Kleitke, B Szokol, L Svajda, Fernando Martín Silva, F Bonechi, M Krekó, S Azami, Antonella Montinaro, Y Wang, V Nikolov, Laura Kaiser, D Bonasera, J Saggau, T Scholz, A Schmitt, Filippo Beleggia, H C Reinhardt, J George, Gianmaria Liccardi, H Walczak, J Tóvári, Johannes Brägelmann, J Montero, M L Sos, L Őrfi, Nieves Peltzer
CDK9 inhibition as an effective therapy for small cell lung cancer. Cell death & disease 15 (5) (2024)
L Valdez Capuccino, T Kleitke, B Szokol, L Svajda, Fernando Martín Silva, F Bonechi, M Krekó, S Azami, Antonella Montinaro, Y Wang, V Nikolov, Laura Kaiser, D Bonasera, J Saggau, T Scholz, A Schmitt, Filippo Beleggia, H C Reinhardt, J George, Gianmaria Liccardi, H Walczak, J Tóvári, Johannes Brägelmann, J Montero, M L Sos, L Őrfi, Nieves Peltzer
CDK9 inhibition as an effective therapy for small cell lung cancer. Cell death & disease 15 (5) (2024)
L Valdez Capuccino, T Kleitke, B Szokol, L Svajda, Fernando Martín Silva, F Bonechi, M Krekó, S Azami, Antonella Montinaro, Y Wang, V Nikolov, Laura Kaiser, D Bonasera, J Saggau, T Scholz, A Schmitt, Filippo Beleggia, H C Reinhardt, J George, Gianmaria Liccardi, H Walczak, J Tóvári, Johannes Brägelmann, J Montero, M L Sos, L Őrfi, Nieves Peltzer
CDK9 inhibition as an effective therapy for small cell lung cancer. Cell death & disease 15 (5) (2024)
L Valdez Capuccino, T Kleitke, B Szokol, L Svajda, Fernando Martín Silva, F Bonechi, M Krekó, S Azami, Antonella Montinaro, Y Wang, V Nikolov, Laura Kaiser, D Bonasera, J Saggau, T Scholz, A Schmitt, Filippo Beleggia, H C Reinhardt, J George, Gianmaria Liccardi, H Walczak, J Tóvári, Johannes Brägelmann, J Montero, M L Sos, L Őrfi, Nieves Peltzer
CDK9 inhibition as an effective therapy for small cell lung cancer. Cell death & disease 15 (5) (2024)
Carina Lorenz, Axel Maximilian Hillmer, Johannes Brägelmann
Predicting the next move: tracking the complexity of lung cancer evolution and metastasis. Signal transduction and targeted therapy 8 (1) (2023)
Nina Müller, Carina Lorenz, Jenny Ostendorp, Felix S Heisel, Ulrich P Friese, Maria Cartolano, Dennis Plenker, Hannah L Tumbrink, Alena Heimsoeth, Philipp Baedeker, Sandra Ortiz-Cuaran, Jonathan Weiss, Reinhard Buttner, Martin Peifer, Roman K Thomas, Martin L Sos, Johannes Berg, Johannes Brägelmann
Characterizing evolutionary dynamics reveals strategies to exhaust the spectrum of subclonal resistance in EGFR-mutant lung cancer. Cancer research (2023)
Lisa Werr, Dennis Plenker, Marcel A Dammert, Carina Lorenz, Johannes Brägelmann, Hannah L Tumbrink, Sebastian Klein, Anna Schmitt, Reinhard Büttner, Thorsten Persigehl, Kevan M Shokat, F Thomas Wunderlich, Alison M Schram, Martin Peifer, Martin L Sos, Hans Christian Reinhardt, Roman K Thomas
CD74-NRG1 Fusions Are Oncogenic In Vivo and Induce Therapeutically Tractable ERBB2:ERBB3 Heterodimerization. Molecular cancer therapeutics 21 (5) (2022)
Fabienne Müller, Jonathan K M Lim, Christina M Bebber, Eric Seidel, Sofya Tishina, Alina Dahlhaus, Jenny Stroh, Julia Beck, Fatma Isil Yapici, Keiko Nakayama, Lucia Torres Fernández, Johannes Brägelmann, Gabriel Leprivier, Silvia von Karstedt
Elevated FSP1 protects KRAS-mutated cells from ferroptosis during tumor initiation. Cell death and differentiation (2022)
Carolin Selenz, Anik Compes, Marieke Nill, Sven Borchmann, Margarete Odenthal, Alexandra Florin, Johannes Brägelmann, Reinhard Buttner, Lydia Meder, Roland T Ullrich
EGFR Inhibition Strongly Modulates the Tumour Immune Microenvironment in EGFR-Driven Non-Small-Cell Lung Cancer. Cancers 14 (16) (2022)
Anna-Lena Lemster, Elisabeth Sievers, Helen Pasternack, Pamela Lazar-Karsten, Niklas Klümper, Verena Sailer, Anne Offermann, Johannes Brägelmann, Sven Perner, Jutta Kirfel
Histone Demethylase KDM5C Drives Prostate Cancer Progression by Promoting EMT. Cancers 14 (8) (2022)
Johannes Brägelmann, Carina Lorenz, Sven Borchmann, Kazuya Nishii, Julia Wegner, Lydia Meder, Jenny Ostendorp, David F Ast, Alena Heimsoeth, Takamasa Nakasuka, Atsuko Hirabae, Sachi Okawa, Marcel A Dammert, Dennis Plenker, Sebastian Klein, Philipp Lohneis, Jianing Gu, Laura K Godfrey, Jan Forster, Marija Trajkovic-Arsic, Thomas Zillinger, Mareike Haarmann, Alexander Quaas, Stefanie Lennartz, Marcel Schmiel, Joshua D'Rozario, Emily S Thomas, Qi-Xiang Li, Clemens A Schmitt, Julie George, Roman K Thomas, Silvia von Karstedt, Gunther Hartmann, Reinhard Buttner, Roland T Ullrich, Jens Thomas Siveke, Kadoaki Ohashi, Martin Schlee, Martin L Sos
MAPK-pathway inhibition mediates inflammatory reprogramming and sensitizes tumors to targeted activation of innate immunity sensor RIG-I. Nature communications 12 (1) (2021)
Johannes Brägelmann, Carol Barahona Ponce, Katherine Marcelain, Stephanie Roessler, Benjamin Goeppert, Ivan Gallegos, Alicia Colombo, Verónica Sanhueza, Erik Morales, María Teresa Rivera, Gonzalo de Toro, Alejandro Ortega, Bettina Müller, Fernando Gabler, Dominique Scherer, Melanie Waldenberger, Eva Reischl, Felix Boekstegers, Valentina Garate-Calderon, Sinan U Umu, Trine B Rounge, Odilia Popanda, Justo Lorenzo Bermejo
Epigenome-Wide Analysis of Methylation Changes in the Sequence of Gallstone Disease, Dysplasia, and Gallbladder Cancer. Hepatology (Baltimore, Md.) 73 (6) (2021)
Diana Schaufler, David F Ast, Hannah L Tumbrink, Nima Abedpour, Lukas Maas, Ayla E Schwäbe, Inga Spille, Stefanie Lennartz, Jana Fassunke, Mihaela Aldea, Benjamin Besse, David Planchard, Lucia Nogova, Sebastian Michels, Carsten Kobe, Thorsten Persigehl, Theresa Westphal, Sophia Koleczko, Rieke Fischer, Jan-Phillip Weber, Janine Altmüller, Roman K Thomas, Sabine Merkelbach-Bruse, Oliver Gautschi, Laura Mezquita, Reinhard Buttner, Jürgen Wolf, Martin Peifer, Johannes Brägelmann, Matthias Scheffler, Martin L Sos
Clonal dynamics of BRAF-driven drug resistance in EGFR-mutant lung cancer. NPJ precision oncology 5 (1) (2021)
Christian Watermann, Helen Pasternack, Christian Idel, Johannes Brägelmann, Patrick Kuppler, Anne Offermann, Danny Jonigk, Mark Philipp Kühnel, Andreas Schröck, Eva Dreyer, Jacqueline Nathansen, Anna Dubrovska, Lars Tharun, Jutta Kirfel, Barbara Wollenberg, Sven Perner, Rosemarie Krupar
Recurrent HNSCC Harbor an Immunosuppressive Tumor Immune Microenvironment Suggesting Successful Tumor Immune Evasion. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (2) (2020)
Dennis Plenker, Maximilian Riedel, Johannes Brägelmann, Marcel A Dammert, Rakhee Chauhan, Phillip P Knowles, Carina Lorenz, Marina Keul, Mike Bührmann, Oliver Pagel, Verena Tischler, Andreas H Scheel, Daniel Schütte, Yanrui Song, Justina Stark, Florian Mrugalla, Yannic Alber, André Richters, Julian Engel, Frauke Leenders, Johannes M Heuckmann, Jürgen Wolf, Joachim Diebold, Georg Pall, Martin Peifer, Maarten Aerts, Kris Gevaert, René P Zahedi, Reinhard Buettner, Kevan M Shokat, Neil Q McDonald, Stefan M Kast, Oliver Gautschi, Roman K Thomas, Martin L Sos
Drugging the catalytically inactive state of RET kinase in RET-rearranged tumors. Science translational medicine 9 (394) (2018)

Johannes Brägelmann.css-eqlu8i{font-size:small;padding-left:4px;} (J Brägelmann)

Publication Activity (10 Years)

Top Topics

Top Venues

Johannes Brägelmann (J Brägelmann)